17-Sep-2020 - New therapies and systemic impact of Spinal Muscular Atrophy

Our team from the Dino Ferrari Center of the University of Milan discusses the advancements and challenges of new therapies for patients with Spinal Muscular […]

09-Sep-2020 - (Italiano) L’Intelligenza Artificiale e le tecnologie digitali in soccorso alla SLA

Sorry, this entry is only available in Italiano.

25-Jun-2020 - (Italiano) SLA: individuato un nuovo metodo per la diagnosi precoce su prelievi di saliva

Sorry, this entry is only available in Italiano.

19-May-2020 - Amyotrophic Lateral Sclerosis: the role of a miRNA identified as a possible therapeutic target

A recent study published on the international journal Progress in neurobiology and carried out by the research group (Dr. Monica Nizzardo and Dr. Mafalda Rizzuti) […]

14-May-2020 - (Italiano) Patologia Neurodegenerativa: iperoralità e allucinazioni i sintomi indicatori

Sorry, this entry is only available in Italiano.

30-Apr-2020 - (Italiano) Ricerca SMA: da SMA Europe un nuovo finanziamento per lo studio della Statmina 2

Sorry, this entry is only available in Italiano.

09-Apr-2020 - (Italiano) Coronavirus informazioni utili: tutto quello che è necessario sapere sul COVID19

Sorry, this entry is only available in Italiano.

17-Mar-2020 - SMARD1 Natural History Study at Centro Dino Ferrari Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico

Spinal muscular atrophy with respiratory distress type 1 (SMARD 1)is a rare, autosomal recessive neuromuscular disease characterized by degeneration of the motor neuron that manifests […]

26-Feb-2020 - (Italiano) Come riconoscere l’Alzheimer: su Starbene i consigli del Prof. Elio Scarpini

Sorry, this entry is only available in Italiano.

25-Feb-2020 - A recent study investigated potential treatment biomarkers of spinal muscular atrophy (SMA) type 3

A recent study published on the Journal of Cellular and Clinical Medicine and conducted by the researchers of the Centro Dino Ferrari, University of Milan, […]

18-Feb-2020 - ALS and SMA: study of molecular mechanisms in resistant neurons identifies a new potential therapeutic target

SYT13 is an oculomotor restricted gene, identified as possible disease modifier of Amyotrophic Lateral Sclerosis and Spinal Muscular Atrophy (SMA), by the researchers of the […]